Case number 1:22-cv-00897
Novo Nordisk Inc. et al v. Sun Pharmaceutical Industries, Inc., et al > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Jun 30, 2023 | 65 | Joint MOTION to Consolidate Cases (Case No. 22-897-CFC and Case No. 22-936-CFC Into Lead Case No. 22-856-CFC) - filed by Novo Nordisk A/S, Novo Nordisk Inc.. (Murray, Travis) (Entered: 06/30/2023) (8) |
| Jun 30, 2023 | 64 | Letter to The Honorable Colm F. Connolly from Travis J. Murray regarding joint motion for consolidation. (Murray, Travis) (Entered: 06/30/2023) (2) |
| Jun 27, 2023 | 63 | SO ORDERED, re 62 Joint STIPULATION and [Proposed] Order of Dismissal as to the Biocon Defendants Regarding the '833 Patent, filed by Novo Nordisk A/S, Novo Nordisk Inc. Signed by Judge Colm F. Connolly on 6/27/2023. (kmd) (Entered: 06/27/2023) (3) |
| Jun 27, 2023 | 62 | Joint STIPULATION and [Proposed] Order of Dismissal as to the Biocon Defendants Regarding the '833 Patent - by Novo Nordisk A/S, Novo Nordisk Inc.. (Murray, Travis) (Entered: 06/27/2023) (3) |
| May 19, 2023 | 61 | NOTICE OF SERVICE of Plaintiffs' Responses and Objections to Sun Pharmaceutical Industries Ltd. and Sun Pharmaceutical Industries, Inc.'s First Set of Requests for Production of Documents and Things (Nos. 1-34) - filed by Novo Nordisk A/S, Novo Nordisk Inc..(Murray, Travis) (Entered: 05/19/2023) (3) |
| Apr 19, 2023 | 60 | NOTICE OF SERVICE of [Sun Pharmaceutical Industries Ltd. and Sun Pharmaceutical Industries, Inc.'s] Requests for Production of Documents and Things (Nos. 1-34) filed by Sun Pharmaceutical Industries Ltd., Sun Pharmaceutical Industries, Inc..(Vrana, Robert) (Entered: 04/19/2023) (2) |
| Mar 24, 2023 | 59 | NOTICE OF SERVICE of Plaintiffs' Notice to Sun of Subpoena for Production of Documents (confidential as to Sun Pharmaceutical Industries Ltd. and Sun Pharmaceutical Industries, Inc.) - filed by Novo Nordisk A/S, Novo Nordisk Inc..(Murray, Travis) (Entered: 03/24/2023) (3) |
| Mar 24, 2023 | 58 | NOTICE OF SERVICE of Plaintiffs' Notice to Biocon of Subpoena for Production of Documents (confidential as to Biocon Limited, Biocon Pharma Limited, and Biocon Pharma, Inc.) - filed by Novo Nordisk A/S, Novo Nordisk Inc..(Murray, Travis) (Entered: 03/24/2023) (5) |
| Mar 2, 2023 | 57 | SO ORDERED, re 54 Joint STIPULATION and Claim Construction Order, ORDER, terminating Deadlines and Hearings: Deadlines listed in this stipulated order have been removed/canceled including the July 20, 2023 Claim Construction Hearing. Signed by Judge Colm F. Connolly on 3/2/2023. (nmf) (Entered: 03/02/2023) (7) |
| Mar 1, 2023 | 56 | NOTICE OF SERVICE of (1) Biocon's responses to Plaintiffs' First Set of Interrogatories (Nos. 1-11); and (2) Biocon's responses to Plaintiffs' First Set of Requests for Production (Nos. 1-73) filed by Biocon Ltd., Biocon Pharma Ltd., Biocon Pharma, Inc..(Dorsney, Kenneth) (Entered: 03/01/2023) (2) |
| Mar 1, 2023 | 55 | NOTICE OF SERVICE of 1) Sun Pharmaceutical Industries Limited and Sun Pharmaceutical Industries, Inc. Objections and Responses to Plaintiffs' First Set of Requests for the Production of Documents and Things (Nos. 1-76); and 2) Sun Pharmaceutical Industries Limited and Sun Pharmaceutical Industries, Inc. Objections and Responses to Plaintiffs' First Set of Collective Interrogatories (Nos. 1-11) filed by Sun Pharmaceutical Industries Ltd., Sun Pharmaceutical Industries, Inc..(Vrana, Robert) (Entered: 03/01/2023) (2) |
| Mar 1, 2023 | 54 | Joint STIPULATION and [Proposed] Claim Construction Order - by Novo Nordisk A/S, Novo Nordisk Inc.. (Murray, Travis) (Entered: 03/01/2023) (7) |
| Feb 15, 2023 | 53 | NOTICE OF SERVICE of Defendants Biocon and Sun's Identification of Proposed Claim Terms for Construction filed by Biocon Ltd., Biocon Pharma Ltd., Biocon Pharma, Inc..(Dorsney, Kenneth) (Entered: 02/15/2023) (2) |
| Feb 14, 2023 | 52 | NOTICE OF SERVICE of Plaintiffs' Identification of Proposed Claim Terms for Construction - filed by Novo Nordisk A/S, Novo Nordisk Inc..(Murray, Travis) (Entered: 02/14/2023) (5) |
| Feb 13, 2023 | 51 | NOTICE OF SERVICE of Novo Nordisk's Initial Responses to Defendants' Invalidity Contentions Regarding U.S. Patent Nos. 8,114,833 and 9,265,893 - filed by Novo Nordisk A/S, Novo Nordisk Inc..(Murray, Travis) (Entered: 02/13/2023) (5) |
| Feb 3, 2023 | 50 | NOTICE OF SERVICE of (1) Plaintiffs' Initial Infringement Contentions as to Biocon Pharma Ltd., Biocon Ltd., and Biocon Pharma, Inc. and (2) Plaintiffs' Initial Infringement Contentions as to Sun Pharmaceutical Industries Ltd. and Sun Pharmaceutical Industries Inc. - filed by Novo Nordisk A/S, Novo Nordisk Inc..(Murray, Travis) (Entered: 02/03/2023) (5) |
| Jan 31, 2023 | 49 | Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Novo Nordisk Commercial Holdings, Inc., Other Affiliate Novo Nordisk A/S, Other Affiliate Novo Nordisk US Holdings Inc. for Novo Nordisk Inc.; Corporate Parent Novo Holdings A/S, Other Affiliate Novo Nordisk Foundation for Novo Nordisk A/S filed by Novo Nordisk A/S, Novo Nordisk Inc.. (Murray, Travis) (Entered: 01/31/2023) (4) |
| Jan 30, 2023 | 48 | NOTICE OF SERVICE of (1) Plaintiffs' First Set of Collective Interrogatories to Defendants (Nos. 1-11), (2) Plaintiffs' First Set of Requests for the Production of Documents and Things (Nos. 1-74) Directed to Defendants Sun Pharmaceutical Industries Ltd. and Sun Pharmacuetical Industries, Inc. and (3) Plaintiffs' First Set of Requests for the Production of Documents and Things (Nos. 1-73) Directed to Defendants Biocon Limited, Biocon Pharma Limited, and Biocon Pharma, Inc. filed by Novo Nordisk A/S, Novo Nordisk Inc..(Murray, Travis) (Entered: 01/30/2023) (7) |
| Jan 27, 2023 | 47 | STIPULATION TO EXTEND TIME for the deadline to generate final lists of search terms to be used to search the parties' Electronically Stored Information to February 3, 2023 - filed by Novo Nordisk A/S, Novo Nordisk Inc.. (Murray, Travis) (Entered: 01/27/2023) (2) |
| Jan 17, 2023 | 46 | NOTICE OF SERVICE of Sun Pharmaceutical Industries Ltd. and Sun Pharmaceutical Industries, Inc. List of ESI Search Terms filed by Sun Pharmaceutical Industries Ltd., Sun Pharmaceutical Industries, Inc..(Vrana, Robert) (Entered: 01/17/2023) (2) |
| Jan 17, 2023 | 45 | NOTICE OF SERVICE of Biocon's Preliminary List of Proposed Search Terms filed by Biocon Ltd., Biocon Pharma Ltd., Biocon Pharma, Inc..(Dorsney, Kenneth) (Entered: 01/17/2023) (2) |
| Jan 13, 2023 | 44 | NOTICE OF SERVICE of Plaintiffs' Disclosure of ESI Search Terms filed by Novo Nordisk A/S, Novo Nordisk Inc..(Murray, Travis) (Entered: 01/13/2023) (5) |
| Dec 29, 2022 | 43 | STIPULATED PROTECTIVE ORDER. Signed by Judge Colm F. Connolly on 12/29/2022. (kmd) (Entered: 12/29/2022) (30) |
| Dec 22, 2022 | 42 | PROPOSED ORDER -- Stipulated Protective Order -- by Novo Nordisk A/S, Novo Nordisk Inc.. (Murray, Travis) (Entered: 12/22/2022) (30) |
| Dec 20, 2022 | 41 | NOTICE OF SERVICE of 1) Sun Pharmaceutical Industries Ltd. and Sun Pharmaceutical Industries, Inc. Initial Noninfringement Contentions, and 2) Defendants' Joint Initial Invalidity Contentions filed by Sun Pharmaceutical Industries Ltd., Sun Pharmaceutical Industries, Inc..(Vrana, Robert) (Entered: 12/20/2022) (2) |
| Dec 20, 2022 | 40 | NOTICE OF SERVICE of Defendant Biocon's Preliminary Non-Infringement Contentions filed by Biocon Ltd., Biocon Pharma Ltd., Biocon Pharma, Inc..(Dorsney, Kenneth) (Entered: 12/20/2022) (2) |
| Dec 16, 2022 | 39 | SO ORDERED, re 37 Stipulation Regarding the Discovery of Electronically Stored Information, filed by Novo Nordisk A/S, Novo Nordisk Inc. Signed by Judge Colm F. Connolly on 12/16/2022. (kmd) (Entered: 12/16/2022) (15) |
| Dec 16, 2022 | 38 | SO ORDERED, re 36 STIPULATION TO EXTEND TIME to submit a proposed Protective Order to December 22, 2022, filed by Novo Nordisk A/S, Novo Nordisk Inc. Signed by Judge Colm F. Connolly on 12/16/2022. (kmd) (Entered: 12/16/2022) (2) |
| Dec 15, 2022 | 37 | STIPULATION and [Proposed] Order Regarding the Discovery of Electronically Stored Information - by Novo Nordisk A/S, Novo Nordisk Inc.. (Murray, Travis) (Entered: 12/15/2022) (15) |
| Dec 15, 2022 | 36 | STIPULATION TO EXTEND TIME to submit a proposed Protective Order to December 22, 2022 - filed by Novo Nordisk A/S, Novo Nordisk Inc.. (Murray, Travis) (Entered: 12/15/2022) (2) |
| Dec 14, 2022 | 35 | SO ORDERED, re 34 STIPULATION TO EXTEND TIME regarding Contentions to, filed by Biocon Pharma, Inc., Biocon Ltd., Biocon Pharma Ltd. Signed by Judge Colm F. Connolly on 12/14/2022. (kmd) (Entered: 12/14/2022) (3) |
| Dec 14, 2022 | 34 | STIPULATION TO EXTEND TIME regarding Contentions to - filed by Biocon Ltd., Biocon Pharma Ltd., Biocon Pharma, Inc.. (Hitch, Cortlan) (Entered: 12/14/2022) (3) |
| Dec 12, 2022 | 33 | SO ORDERED, re 32 STIPULATION TO EXTEND TIME to Submit Proposed ESI Order and Protective Order to December 15, 2022, filed by Sun Pharmaceutical Industries, Inc., Sun Pharmaceutical Industries Ltd. Signed by Judge Colm F. Connolly on 12/12/2022. (kmd) (Entered: 12/12/2022) (2) |
| Dec 9, 2022 | 32 | STIPULATION TO EXTEND TIME to Submit Proposed ESI Order and Protective Order to December 15, 2022 - filed by Sun Pharmaceutical Industries Ltd., Sun Pharmaceutical Industries, Inc.. (Vrana, Robert) (Entered: 12/09/2022) (2) |
| Nov 30, 2022 | 31 | NOTICE OF SERVICE of Defendant Biocon's Initial 26(a) and Paragraph 3 Disclosures filed by Biocon Ltd., Biocon Pharma Ltd., Biocon Pharma, Inc..(Dorsney, Kenneth) (Entered: 11/30/2022) (2) |
| Nov 29, 2022 | 30 | SO ORDERED, re 28 Stipulation to Extend the Deadline to Submit ESI Order and Protective Order, filed by Novo Nordisk A/S, Novo Nordisk Inc. Signed by Judge Colm F. Connolly on 11/29/2022. (kmd) (Entered: 11/29/2022) (2) |
| Nov 29, 2022 | 29 | NOTICE OF SERVICE of (1) Plaintiffs' Disclosures to Biocon Pharma Ltd., Biocon Ltd., and Biocon Pharma, Inc. Under Paragraph 3 of the District of Delaware Default Standard; and (2) Plaintiffs' Disclosures to Biocon Pharma Ltd., Biocon Ltd., and Biocon Pharma, Inc. Pursuant to Rule 26(a)(1) of the Federal Rules of Civil Procedure - filed by Novo Nordisk A/S, Novo Nordisk Inc..(Murray, Travis) (Entered: 11/29/2022) (5) |
| Nov 29, 2022 | 28 | STIPULATION and [Proposed] Order to Extend the Deadline to Submit ESI Order and Protective Order - by Novo Nordisk A/S, Novo Nordisk Inc.. (Murray, Travis) (Entered: 11/29/2022) (2) |
| Nov 28, 2022 | 27 | SO ORDERED, re 25 STIPULATION TO EXTEND TIME for Plaintiffs and Biocon to make their disclosures required by FED. R. CIV. P. 26(a)(1) and their initial disclosures required by Paragraph 3 of the District of Delaware Default Standard to November 29, 2022, filed by Novo Nordisk A/S, Novo Nordisk Inc. Signed by Judge Colm F. Connolly on 11/28/2022. (kmd) (Entered: 11/28/2022) (2) |
| Nov 22, 2022 | 26 | NOTICE OF SERVICE of 1) Initial Disclosures of Sun Pharmaceutical Industries Ltd. and Sun Pharmaceutical Industries, Inc., and 2) Initial Disclosures of Sun Pharmaceutical Industries Ltd. and Sin Pharmaceutical Industries, Inc., Pursuant to Paragraph 3 of the Default Standard for Discovery filed by Sun Pharmaceutical Industries Ltd., Sun Pharmaceutical Industries, Inc..(Vrana, Robert) (Entered: 11/22/2022) (2) |
| Nov 22, 2022 | 25 | STIPULATION TO EXTEND TIME for Plaintiffs and Biocon to make their disclosures required by FED. R. CIV. P. 26(a)(1) and their initial disclosures required by Paragraph 3 of the District of Delaware Default Standard to November 29, 2022 - filed by Novo Nordisk A/S, Novo Nordisk Inc.. (Murray, Travis) (Entered: 11/22/2022) (2) |
| Nov 22, 2022 | 24 | NOTICE OF SERVICE of (1) Plaintiffs' Disclosures Under Paragraph 3 of the District of Delaware Default Standard; and (2) Plaintiffs' Disclosures Pursuant to Rule 26(a)(1) of the Federal Rules of Civil Procedure filed by Novo Nordisk A/S, Novo Nordisk Inc..(Murray, Travis) (Entered: 11/22/2022) (3) |
| Nov 14, 2022 | 23 | NOTICE OF SERVICE of Plaintiffs' Preliminary Disclosure of Asserted Claim filed by Novo Nordisk A/S, Novo Nordisk Inc..(Murray, Travis) (Entered: 11/14/2022) (3) |
| Nov 14, 2022 | 22 | NOTICE OF SERVICE of Plaintiffs' Preliminary Disclosure of Asserted Claims filed by Novo Nordisk A/S, Novo Nordisk Inc..(Murray, Travis) (Entered: 11/14/2022) (4) |
| Nov 11, 2022 | 21 | NOTICE of Change of Firm Affiliation of Co-Counsel by Sun Pharmaceutical Industries Ltd., Sun Pharmaceutical Industries, Inc. (Vrana, Robert) (Entered: 11/11/2022) (4) |
| Nov 8, 2022 | 20 | SCHEDULING & CONSOLIDATION ORDER: THESE ACTIONS ARE CONSOLIDATED FOR ALL PURPOSES AND ALL FUTURE FILINGS SHALL BE MADE IN LEAD CASE NO. 22-CV-897-CFC ONLY. The captions shall be modified to include the words "ANDA CASE" immediately below the Civil Action Number. Joinder of Parties due by 8/11/2023. Amended Pleadings due by 8/11/2023. Fact Discovery completed by 9/8/2023. Expert Discovery due by 1/19/2024. Joint Claim Construction Brief due by 5/23/2023. A Markman Hearing is set for 6/27/2023 at 09:00 AM in Courtroom 4B before Judge Colm F. Connolly. Proposed Pretrial Order due by 3/19/2024. A Final Pretrial Conference is set for 4/9/2024 at 03:00 PM in Courtroom 4B before Judge Colm F. Connolly. A Bench Trial is set for 4/15/2024 at 08:30 AM in Courtroom 4B before Judge Colm F. Connolly. Signed by Judge Colm F. Connolly on 11/8/2022. (nmf) (Entered: 11/08/2022) (30) |
| Nov 1, 2022 | 19 | PROPOSED ORDER -- Scheduling Order -- re (16 in 1:22-cv-00936-CFC, 16 in 1:22-cv-00936-CFC) Order,,, Set Deadlines,, (14 in 1:22-cv-00897-CFC, 14 in 1:22-cv-00897-CFC) Order,,, Set Deadlines,, by Novo Nordisk A/S, Novo Nordisk Inc.. (Attachments: # 1 Letter to The Honorable Colm F. Connolly)(Murray, Travis) (Entered: 11/01/2022) (Letter to The Honorable Colm F. Connolly) (1) |
| Nov 1, 2022 | 19 | PROPOSED ORDER -- Scheduling Order -- re (16 in 1:22-cv-00936-CFC, 16 in 1:22-cv-00936-CFC) Order,,, Set Deadlines,, (14 in 1:22-cv-00897-CFC, 14 in 1:22-cv-00897-CFC) Order,,, Set Deadlines,, by Novo Nordisk A/S, Novo Nordisk Inc.. (Attachments: # 1 Letter to The Honorable Colm F. Connolly)(Murray, Travis) (Entered: 11/01/2022) (Main Document) (30) |
| Oct 26, 2022 | 18 | STIPULATION TO EXTEND TIME to submit a proposed scheduling order to November 1, 2022 - filed by Novo Nordisk A/S, Novo Nordisk Inc.. (Murray, Travis) (Entered: 10/26/2022) (2) |
| Oct 20, 2022 | 17 | STIPULATION TO EXTEND TIME for the parties to submit a proposed scheduling order to October 27, 2022 - filed by Novo Nordisk A/S, Novo Nordisk Inc.. (Egan, Brian) (Entered: 10/20/2022) (2) |
| Oct 20, 2022 | 16 | Letter to The Honorable Colm F. Connolly from Brian P. Egan regarding case coordination - re (16 in 1:22-cv-00936-CFC, 16 in 1:22-cv-00936-CFC) Order,,, Set Deadlines,, (14 in 1:22-cv-00897-CFC, 14 in 1:22-cv-00897-CFC) Order,,, Set Deadlines,,. (Egan, Brian) (Entered: 10/20/2022) (2) |
| Oct 4, 2022 | 15 | ANSWER to 11 Answer to Complaint, Counterclaim (Plaintiffs' Answer to Sun Pharmaceutical Industries Ltd.'s Counterclaims) - by Novo Nordisk A/S, Novo Nordisk Inc..(Murray, Travis) (Entered: 10/04/2022) (14) |
| Sep 20, 2022 | 14 | ORDER, These cases having been recently joined and as these cases are listed as related to earlier filed cases that are currently proceeding on an agreed upon schedule entered by the Court; IT IS ORDERED that, on or before October 20, 2022, counsel for the parties shall confer regarding coordination of the cases and submit a proposed scheduling order to the Court or otherwise advise the Court that a separate scheduling conference is needed. ORDER, Setting Deadlines: ( Notice of Compliance deadline set for 10/20/2022.) Signed by Judge Colm F. Connolly on 9/20/2022. (nmf) (Entered: 09/20/2022) (2) |
| Sep 14, 2022 | 13 | MOTION for Pro Hac Vice Appearance of Attorney Stephen P. Benson and Kimberly A. Beis - filed by Sun Pharmaceutical Industries Ltd., Sun Pharmaceutical Industries, Inc.. (Vrana, Robert) (Entered: 09/14/2022) (6) |
| Sep 13, 2022 | 12 | Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Sun Pharmaceutical Industries Ltd. for Sun Pharmaceutical Industries, Inc. filed by Sun Pharmaceutical Industries Ltd., Sun Pharmaceutical Industries, Inc.. (Gaza, Anne) (Entered: 09/13/2022) (3) |
| Sep 13, 2022 | 11 | ANSWER to 1 Complaint, , COUNTERCLAIM against All Plaintiffs by Sun Pharmaceutical Industries, Inc., Sun Pharmaceutical Industries Ltd..(Gaza, Anne) (Entered: 09/13/2022) (30) |
| Sep 2, 2022 | 10 | STIPULATION TO EXTEND TIME to move, answer, or otherwise respond to the Complaint to September 13, 2022 - filed by Sun Pharmaceutical Industries Ltd., Sun Pharmaceutical Industries, Inc.. (Gaza, Anne) (Entered: 09/02/2022) (2) |
| Aug 22, 2022 | 9 | MOTION for Pro Hac Vice Appearance of Attorney Jeffrey J. Oelke, Ryan P. Johnson, Robert E. Counihan, Laura T. Moran, Erica R. Sutter and Olivia L. Wheeling - filed by Novo Nordisk A/S, Novo Nordisk Inc.. (Egan, Brian) (Entered: 08/22/2022) (12) |
| Jul 19, 2022 | 8 | Waiver of Service Executed (1) Docket Text: WAIVER OF SERVICE returned executed by Novo Nordisk Inc., Novo Nordisk A/S: For Sun Pharmaceutical Industries, Inc. waiver sent on 7/6/2022, answer due 9/6/2022. (Egan, Brian) |
| Jul 19, 2022 | 7 | Waiver of Service Executed (1) Docket Text: WAIVER OF SERVICE returned executed by Novo Nordisk Inc., Novo Nordisk A/S: For Sun Pharmaceutical Industries Ltd. waiver sent on 7/6/2022, answer due 9/6/2022. (Egan, Brian) |
| Jul 6, 2022 | N/A | Case Assigned/Reassigned (0) Docket Text: Case Assigned to Judge Colm F. Connolly. Please include the initials of the Judge (CFC) after the case number on all documents filed. (rjb) |
| Jul 1, 2022 | 1 | Complaint* (1) |
| Jul 1, 2022 | 6 | Summons Issued (2) |
| Jul 1, 2022 | 6 | Main Document (2) Docket Text: Summons Issued as to Sun Pharmaceutical Industries Ltd. on 7/1/2022; Sun Pharmaceutical Industries, Inc. on 7/1/2022. (Attachments: # (1) Summons Issued)(srs) |
| Jul 1, 2022 | 5 | Disclosure Statement (2) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Novo Nordisk A/S and Corporate Parent Novo Nordisk US Holdings, Inc. for Novo Nordisk Inc. filed by Novo Nordisk A/S and Novo Nordisk Inc. (srs) |
| Jul 1, 2022 | 4 | Patent/Trademark Report to Commissioner (1) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 8,579,869 B2 ;7,762,994 B2 ;8,114,833 B2 ;9,265,893 B2. (srs) |
| Jul 1, 2022 | 3 | ANDA Form (1) Docket Text: Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 5/19/2022. Date of Expiration of Patent: See Attached.Thirty Month Stay Deadline: 11/19/2024. (srs) |
| Jul 1, 2022 | 2 | Magistrate Consent Forms (3) Docket Text: Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (srs) |
| Jul 1, 2022 | 1 | Civil Cover Sheet (2) |
| Jul 1, 2022 | 1 | Exhibit A-D (62) |
| Jul 1, 2022 | 1 | Main Document (10) Docket Text: COMPLAINT filed against Sun Pharmaceutical Industries Ltd., Sun Pharmaceutical Industries, Inc. ( Filing fee $ 402, receipt number ADEDC-3908452.) - filed by Novo Nordisk Inc., Novo Nordisk A/S. (Attachments: # (1) Exhibit A-D, # (2) Civil Cover Sheet)(srs) |
